Changes of laminin β2 chain expression in congenital muscular dystrophy
- 30 September 1997
- journal article
- Published by Elsevier BV in Neuromuscular Disorders
- Vol. 7 (6-7), 373-378
- https://doi.org/10.1016/s0960-8966(97)00072-2
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Laminin β2 chain and adhalin deficiency in the skeletal muscle of Walker‐Warburg syndrome (cerebroocular dysplasia‐muscular dystrophy)Neurology, 1995
- Mutations in the laminin α2–chain gene (LAMA2) cause merosin–deficient congenital muscular dystrophyNature Genetics, 1995
- Expression of laminin subunits in congenital muscular dystrophyNeuromuscular Disorders, 1995
- Lissencephaly and Other Malformations of Cortical Development: 1995 UpdateNeuropediatrics, 1995
- Preserved Merosin M-Chain (or Laminin-α2) Expression in Skeletal Muscle Distinguishes Walker-Warburg Syndrome from Fukuyama Muscular Dystrophy and Merosin-Deficient Congenital Muscular DystrophyNeuropediatrics, 1995
- Localization of merosin-negative congenital muscular dystrophy to chromosome 6q2 by homozygosity mappingHuman Molecular Genetics, 1994
- Localization of a gene for Fukuyama type congenital muscular dystrophy to chromosome 9q31–33Nature Genetics, 1993
- Abnormal localization of laminin subunits in muscular dystrophiesJournal of the Neurological Sciences, 1993
- Fukuyama Type Congenital Progressive Muscular DystrophyPediatrics International, 1991
- Congenital progressive muscular dystrophy of the fukuyama type — clinical, genetic and pathological considerations —Brain & Development, 1981